Short interest in Regulus Therapeutics Inc (NASDAQ:RGLS) decreased during the last reporting period, falling from 2.50M to 1.69M. This put 3.28% of the company's publicly available shares short.

Short interest for Regulus Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Regulus Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 509.12K shares traded per day, it would take 3.32 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.